HCA Healthcare Q1 EPS $4.85 beats prior year; raises 2023 revenue and profit guidance

HCA Healthcare, Inc.

2023-Q1 EPS reported $4.85 revenue$15,591,000,000

Q1 revenues $15.591B (up 4.3% YoY); net income $1.363B, diluted EPS $4.85 vs $4.14.
Adjusted EBITDA $3.172B vs $2.944B; same facility admissions +4.4%, equivalent admissions +7.5%.
Board declared $0.60/share dividend payable June 30, 2023, record June 16.
Repurchased 3.34M shares for $846M in Q1; $3.74B remaining under authorization.
2023 guidance raised: revenue $62.5-64.5B; EPS $17.25-18.55; Adjusted EBITDA $12.1-12.7B.

item 2.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HCA Healthcare, Inc. reported first quarter ended March 31, 2023 results: revenue $15.591 billion, net income $1.363 billion, EPS $4.85 per diluted share.

Period: first quarter ended March 31, 2023
Revenue: $15.591 billion
Net income: $1.363 billion
EPS: $4.85 per diluted share
Result: reported results

Exact text from the filing

Revenues in the first quarter of 2023 increased to $15.591 billion, compared to $14.945 billion in the first quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.363 billion, or $4.85 per diluted share, compared to $1.273 billion, or $4.14 per diluted share, in the first quarter of 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

HCA Healthcare, Inc. reported Full year 2023 results: revenue $62.5 to $64.5 billion, net income $4.750 to $5.160 billion, EPS $17.25 to $18.55 per diluted share. Guidance raised.

Period: Full year 2023
Revenue: $62.5 to $64.5 billion
Net income: $4.750 to $5.160 billion
EPS: $17.25 to $18.55 per diluted share
Guidance: raised
Result: guidance update

Exact text from the filing

The 2023 guidance ranges for the year have been revised from our fourth quarter release as follows: Previous 2023 Guidance Range as of January 27, 2023 2023 Guidance Range as of April 21, 2023 Revenues $61.5 to 63.5 billion $62.5 to $64.5 billion Net Income Attributable to HCA Healthcare, Inc. $4.525 to $4.895 billion $4.750 to $5.160 billion Adjusted EBITDA $11.8 to $12.4 billion $12.1 to $12.7 billion EPS (diluted) $16.40 to $17.60 per diluted share $17.25 to $18.55 per diluted share

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-109258

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.